Gw Pharmaceuticals Plc

Sativex(R) Marketed to Treat Spasticity Associated with Multiple Sclerosis

Older News

PORTON DOWN, England, June 21, 2010 - GW Pharmaceuticals plc (GWP:AIM) today announces the UK launch of Sativex(R), its Oromucosal Spray for the treatment of spasticity due to Multiple Sclerosis (MS).

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy